Amgen stock drops 1.19% as Phase 3 data supports early LDL-C lowering in high-risk CV patients

Traders Union
All News
Companies
Amgen slides 1.19% to $348.95 today

Highlights

AMGN remains under short- and medium-term bearish pressure, trading below key moving averages despite structural support from the long-term trend.
Short-term momentum is decisively bearish, with multiple oscillators reflecting selling pressure and oversold conditions after a 1.19% decline today.
Near-term price is expected to consolidate in a $345.00–$360.00 range, with technical signals favoring stabilization or a rebound over a breakdown.

AMGN is currently trading below its MA-20 ($363.68) and MA-50 ($361.80), signaling persistent short- and medium-term bearish pressure, though it remains well above the longer-term MA-200 ($318.11), which continues to provide structural support. The Ichimoku Kijun at $368.17 sits above the current price, acting as immediate resistance; near-term support is found at MA-100 ($345.54), with key support at MA-200 ($318.11), while near-term resistance clusters near MA-20/MA-50 ($363.68–$361.80) and key resistance is marked by the Ichimoku Kijun ($368.17).

Momentum signals on D1 remain decisively bearish, with MACD and ADX showing downward momentum and limited current trend strength. Oversold readings from RSI, Stoch RSI, and CCI highlight stretched short-term conditions, while BBP also signals dominant seller pressure intraday. Although the Awesome Oscillator is neutral, most oscillators confirm downside momentum. In today's session, AMGN has dropped 1.19%, underlining strong short-term selling interest. Over the past week, AMGN is trading at $348.95, up from $347.49 a week ago—a modest 0.42% gain. Price action lies in the lower part of the weekly range, with weekly volatility standing at 3.53%. The week has seen a recovery from the low, but the overall tone is one of consolidation beneath resistance.

Looking ahead, the expected price range for the coming week is $345.00 to $360.00, normalized in line with recent volatility and centered near current levels. Weekly signals—RSI-W1 (Buy), ADX-W1 (Buy), MACD-W1 (Strong Buy), and rising MA-50-W1—all indicate a very high probability (more than 80%) that AMGN will attempt to stabilize or rebound, making a short-term downturn less likely. The baseline scenario envisions AMGN holding within a sideways corridor, anchored between recent supports and resistance. A bullish scenario would see a decisive push above $363.68, opening room toward $368.17. Conversely, a bearish break below $345.54 could trigger a move toward $340.00 and beyond. The forecast range remains well above the 52-week low ($261.43) but short of the recent high ($391.29), indicating AMGN is consolidating near the middle/lower part of its annual range.

Loading...

The tweet was deleted by the author.

But we saved everything 🙂.

Earlier, analysts noted that Amgen's shares were consolidating in a stable long-term trend, albeit with near-term uncertainty. In light of recent developments, the prevailing scenario now calls for investors to monitor key support levels closely, as any decisive move could signal the next meaningful shift in trend.

This material may contain third-party opinions, none of the data and information on this webpage constitutes investment advice according to our Disclaimer. While we adhere to strict Editorial Integrity, this post may contain references to products from our partners.